Bicycle Therapeutics (BCYC) Debt to Equity (2020 - 2024)
Bicycle Therapeutics (BCYC) reported Debt to Equity of $0.04 for Q2 2024, down 74.48% on a YoY basis from $0.14 in Q3 2023, and down 59.11% quarter-over-quarter from $0.09 in Q1 2024.
Bicycle Therapeutics (BCYC) Debt to Equity (2020 - 2024) Analysis & Trends
Bicycle Therapeutics has reported Debt to Equity for 5 years, with the latest figure at $0.04 in Q2 2024.
- For the quarter ending Q2 2024, Debt to Equity fell 74.48% year-over-year to $0.04; the trailing twelve-month figure through Jun 2024 stood at $0.04 (down 74.48% YoY), and the FY2023 full-year result was $0.08, down 26.08% from the prior year.
- Debt to Equity for Q2 2024 stood at $0.04, down from $0.09 in the prior quarter.
- The five-year high for Debt to Equity was $0.21 in Q2 2021, with the low at $0.04 in Q2 2024.
- Historically, Debt to Equity has averaged $0.12 across 5 years, with a median of $0.11 in 2022.
- Annual changes were most pronounced in 2023 — Debt to Equity surged 43.21% — and 2024, when it plunged 74.48%.
- Bicycle Therapeutics' Debt to Equity stood at $0.15 in 2020, then sank by 43.22% to $0.09 in 2021, then climbed by 29.76% to $0.11 in 2022, then fell by 26.08% to $0.08 in 2023, then sank by 57.26% to $0.04 in 2024.
- The last three Debt to Equity figures came in at $0.04 (Q2 2024), $0.09 (Q1 2024), and $0.08 (Q4 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt/Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.32 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Bicycle Therapeutics | 278.04 Mn | 278.04 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 0.04 |
| Mar 31, 2024 | 0.09 |
| Dec 31, 2023 | 0.08 |
| Sep 30, 2023 | 0.07 |
| Jun 30, 2023 | 0.14 |
| Mar 31, 2023 | 0.13 |
| Dec 31, 2022 | 0.11 |
| Sep 30, 2022 | 0.10 |
| Jun 30, 2022 | 0.10 |
| Mar 31, 2022 | 0.09 |
| Dec 31, 2021 | 0.09 |
| Sep 30, 2021 | 0.17 |
| Jun 30, 2021 | 0.21 |
| Mar 31, 2021 | 0.21 |
| Dec 31, 2020 | 0.15 |
| Sep 30, 2020 | 0.13 |